Koyfin Home > Directory > Health Care > Inovio Pharma > Gross Margin

Inovio Pharma Gross Margin Chart (INO)

Inovio Pharma annual/quarterly Gross Margin from 2010 to 2020. Gross margin is a company's total sales revenue minus its cost of goods sold (COGS), divided by total sales revenue, expressed as a percentage. The higher the percentage, the more the company retains on each dollar of sales, to service its other costs and debt obligations.
  • Inovio Pharma Gross Margin for the quarter ending June 06, 2020 was $-8,275m a 77.18% decrease of -6,386m year over year
  • Inovio Pharma Gross Margin for the last 12 months ending June 06, 2020 was $-2,845m a 53.32% decrease of -1,517m year over year
  • Inovio Pharma Annual Gross Margin for 2019 was $-1,994m a 89.34% decrease of -1,782m from 2018
  • Inovio Pharma Annual Gross Margin for 2018 was $-213m a 37.19% decrease of -79m from 2017
  • Inovio Pharma Annual Gross Margin for 2017 was $-133m a -13.00% increase of 17m from 2016
Other Margins & Efficiency Metrics:
  • Inovio Pharma EBITDA Margin for the quarter ending June 06, 2018 was $-16m a -1,153.83% increase of 186m year over year
  • Inovio Pharma Return on Capital % for the quarter ending December 12, 2018 was -77.33 a 17.16% decrease of -13.27 year over year
  • Inovio Pharma Return on Equity % for the quarter ending December 12, 2018 was -138.25 a 26.75% decrease of -36.99 year over year
View Chart On Koyfin

Quarterly INO Gross Margin Data

06/2020$-8,275m
03/2020$-1,340m
12/2019$-7,773m
09/2019$-1,888m
06/2019$-16,474m
03/2019$-762m
12/2018$-954m
09/2018$-992m
06/2018$8m
03/2018$-1,507m

Annual INO Gross Margin Data

2019$-1,994m
2018$-213m
2017$-133m
2016$-151m
2015$-42m
2014$-226m
2013$-59m
2012$-337m
2011$-105m
2010$-106m